BMJ  2007;335:974 (10 November), doi:10.1136/bmj.39335.385301.BE (published 1 November 2007)

Research

Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis

Leanne Bellamy, medical student1, Juan-Pablo Casas, clinical lecturer2, Aroon D Hingorani, reader3, David J Williams, consultant obstetric physician4

1 Imperial College School of Medicine, London, 2 Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, 3 British Heart Foundation Laboratories, Department of Medicine, University College London, 4 Institute for Women's Health, Elizabeth Garrett Anderson Obstetric Hospital, University College London, London WC1E 6DH

Correspondence to: D J Williams d.williams{at}uclh.nhs.uk

Objective To quantify the risk of future cardiovascular diseases, cancer, and mortality after pre-eclampsia.

Design Systematic review and meta-analysis.

Data sources Embase and Medline without language restrictions, including papers published between 1960 and December 2006, and hand searching of reference lists of relevant articles and reviews for additional reports.

Review methods Prospective and retrospective cohort studies were included, providing a dataset of 3 488 160 women, with 198 252 affected by pre-eclampsia (exposure group) and 29 495 episodes of cardiovascular disease and cancer (study outcomes).

Results After pre-eclampsia women have an increased risk of vascular disease. The relative risks (95% confidence intervals) for hypertension were 3.70 (2.70 to 5.05) after 14.1 years weighted mean follow-up, for ischaemic heart disease 2.16 (1.86 to 2.52) after 11.7 years, for stroke 1.81 (1.45 to 2.27) after 10.4 years, and for venous thromboembolism 1.79 (1.37 to 2.33) after 4.7 years. No increase in risk of any cancer was found (0.96, 0.73 to 1.27), including breast cancer (1.04, 0.78 to 1.39) 17 years after pre-eclampsia. Overall mortality after pre-eclampsia was increased: 1.49 (1.05 to 2.14) after 14.5 years.

Conclusions A history of pre-eclampsia should be considered when evaluating risk of cardiovascular disease in women. This association might reflect a common cause for pre-eclampsia and cardiovascular disease, or an effect of pre-eclampsia on disease development, or both. No association was found between pre-eclampsia and future cancer.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Related Articles

Migraine, vascular risk, and cardiovascular events in women: prospective cohort study
Tobias Kurth, Markus Schürks, Giancarlo Logroscino, J Michael Gaziano, and Julie E Buring
BMJ 2008 337: a636. [Abstract] [Full Text] [PDF]

Pre-eclampsia and increased cardiovascular risk
L A Magee and P von Dadelszen
BMJ 2007 335: 945-946. [Extract] [Full Text] [PDF]

The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community
Fiona Milne, Chris Redman, James Walker, Philip Baker, Julian Bradley, Carol Cooper, Michael de Swiet, Gillian Fletcher, Mervi Jokinen, Deirdre Murphy, Catherine Nelson-Piercy, Vicky Osgood, Stephen Robson, Andrew Shennan, Angela Tuffnell, Sara Twaddle, and Jason Waugh
BMJ 2005 330: 576-580. [Full Text] [PDF]

This article has been cited by other articles:

  • Kurth, T., Schurks, M., Logroscino, G., Gaziano, J M., Buring, J. E (2008). Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ 337: a636-a636 [Abstract] [Full text]  
  • Craici, I., Wagner, S., Garovic, V. D. (2008). Review: Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test?. Therapeutic Advances in Cardiovascular Disease 2: 249-259 [Abstract]  
  • Anastasakis, E., Paraskevas, K. I., Papantoniou, N., Daskalakis, G., Mesogitis, S., Mikhailidis, D. P., Antsaklis, A. (2008). Association Between Abnormal Uterine Artery Doppler Flow Velocimetry, Risk of Preeclampsia, and Indices of Arterial Structure and Function: A Pilot Study. ANGIOLOGY 59: 493-499 [Abstract]  
  • Hubel, C. A., Powers, R. W., Snaedal, S., Gammill, H. S., Ness, R. B., Roberts, J. M., Arngrimsson, R. (2008). C-Reactive Protein Is Elevated 30 Years After Eclamptic Pregnancy. Hypertension 51: 1499-1505 [Abstract] [Full text]  
  • Sibai, B. M. (2008). Intergenerational Factors: A Missing Link for Preeclampsia, Fetal Growth Restriction, and Cardiovascular Disease?. Hypertension 51: 993-994 [Full text]  
  • Chappell, L. C., Enye, S., Seed, P., Briley, A. L., Poston, L., Shennan, A. H. (2008). Adverse Perinatal Outcomes and Risk Factors for Preeclampsia in Women With Chronic Hypertension: A Prospective Study. Hypertension 51: 1002-1009 [Abstract] [Full text]  
  • Thachil, J. V (2007). Pre-eclampsia is an inflammatory disorder. BMJ 335: 1059-1059 [Full text]  
  • Magee, L A, Dadelszen, P v. (2007). Pre-eclampsia and increased cardiovascular risk. BMJ 335: 945-946 [Full text]  

Rapid Responses:

Read all Rapid Responses

Abnormal uterine artery Doppler flow velocimetry and risk of pre-eclampsia/future cardiovascular disease
Dimitri P. Mikhailidis, et al.
bmj.com, 6 Nov 2007 [Full text]
The association of pre-eclampsia and cardiovascular disease.
Srijit Das
bmj.com, 7 Nov 2007 [Full text]



Student BMJ

Intimate examinations

Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.

www.student.bmj.com

Listen to the latest BMJ Interview